NOI bridge sole source quidelortho

The Defense Health Agency has issued a Notice of Intent (NOI) regarding a sole source bridge contract award to QuidelOrtho Sales Company, LLC for medical diagnostic analyzers and related services. This special notice was posted on November 6, 2025, and pertains to the procurement of Integrated System Cost Per Reportable Chemistry Analyzers for the 633rd Medical Group at Langley-Eustis Air Force Base. The contract falls under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) and PSC code 6630 (Chemical Analysis Instruments). The Defense Health Agency is a defense-aligned federal agency responsible for health-related procurement and operations. This sole source designation indicates the agency has determined that QuidelOrtho possesses unique capabilities or qualifications necessary for this requirement.

The primary objective of this bridge contract is to supply medical diagnostic analyzers, test equipment, validation supplies, and reagents to support laboratory operations, with the contract performance period running from December 2, 2025, through September 30, 2026, and including an optional 6-month extension. QuidelOrtho will be required to provide comprehensive 24/7 support services including equipment repairs, troubleshooting, and maintenance to enable the laboratory to perform approximately 40 different medical tests with estimated annual volumes ranging from 500 to 40,417 tests. Interested parties must submit a five-page capability statement by 2:00 PM EST on November 10, 2025, to karl.o.molina.civ@health.mil to express interest in this opportunity. There are no set-aside restrictions on this procurement, meaning all qualified contractors meeting the technical requirements are eligible to participate. This sole source notification allows other capable vendors a brief opportunity to present alternative solutions or challenge the sole source justification before contract award.